Sun Pharma commercially launches Amifostine
New Delhi, Mar 31 (UNI) Sun Pharmaceutical Industries Ltd today said it has commercially launched generic Amifostine for Injection 500mg, which is therapeutically equivalent to Medlmmune's Ethyol.
The company's product is being sold in the US by its marketing partner Caraco Pharmaceutical Laboratories, said a statement.
The firm had received a USFDA approval for this earlier in March 2008.
Ethyoi has annual sales of approximately 80 million dollars in the US.
Sun Pharma, being the first-to-file an ANDA for generic Ethyol, has a 180-day marketing exclusivity.
UNI PBB SR DS1145
More From
-
LPG Crunch: Karnataka Brings New SOPs, Makes PNG Registration Mandatory for Businesses -
Hyderabad Gold Silver Rate Today, 30 March 2026: Check Fresh 24K, 22K, 18K Gold And Silver Prices In City -
Opinion Poll For Kerala Assembly Election 2026: Ldf Strength In Kannur And Kasaragod -
Tamil Nadu Polls 2026: Vijay Reveals Rs 645 Crore Assets, Rs 266 Crore in Banks; Know All His Declaration -
Mumbai Metro Line 9 Set for April 3 Launch, Dahisar-Mira Bhayandar to Get Direct Boost -
Trump Hints At Breakthrough With Iran Amid War Escalation, Calls Recent Move A ‘Sign Of Respect’ -
Rahul Arunoday Banerjee Autopsy Report: Actor Was Underwater For Over An Hour, Sand Found In Lungs -
West Bengal Assembly elections: Election Commission transfers heads of 173 police stations -
Delhi Weather Brings Relief: IMD Issues Yellow Alert For Rain, Thunderstorms And Gusty Winds; Check Forecast -
Tamil Nadu Elections 2026: Vijay Files Nomination Same Day as MK Stalin, Sets Up Symbolic Political Face-Off -
Too Close To Call? 57 Key Seats Could Decide West Bengal Election 2026 As TMC And BJP Gear Up For Tight Battle -
IPL 2026 RR vs CSK Live Streaming: How to Watch Rajasthan Royals vs Chennai Super Kings Match Today
Click it and Unblock the Notifications
Sign in with Google